palmidrol has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although subcutaneous administration of interferon (IFN)-β1a is approved as first-line therapy for the treatment of relapsing-remitting MS (RR-MS), its commonly reported adverse events (AEs) such as pain, myalgia, and erythema at the injection site, deeply affect the quality of life (QoL) of patients with MS." | 2.82 | Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis. ( Alhouayek, M; Barbato, F; Calignano, A; Carotenuto, A; Comelli, A; Montella, S; Muccioli, GG; Orefice, G; Orefice, NS, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orefice, NS | 1 |
| Alhouayek, M | 1 |
| Carotenuto, A | 1 |
| Montella, S | 1 |
| Barbato, F | 1 |
| Comelli, A | 1 |
| Calignano, A | 1 |
| Muccioli, GG | 1 |
| Orefice, G | 1 |
1 trial available for palmidrol and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Topics: Administration, Oral; Adult; Amides; Anti-Inflammatory Agents; Cytokines; Disease Progression; Doubl | 2016 |